ArticleJournal of pharmaceutical and biomedical analysis2025

Characterizing the metabolites of the tyrosine-kinase inhibitor pexidartinib in mouse feces, urine, plasma, and liver.

Xuan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.